Business
CAIT urge government to take action against e-pharmacy companies, including Amazon, Flipkart, Reliance
Training its guns on e-pharmacy companies, Confederation of All India Traders (CAIT) on Monday strongly raised the issue of malpractices being conducted in online pharmacy trade.
CAIT alleged that primarily Pharmeasy, Medlife, 1Mg, Netmeds (now owned by Reliance Group), Amazon (foreign company owned by Amazon) Flipkart (owned by foreign company Walmart) are conducting business practices in contravention of provisions of The Drug & Cosmetics Act, 1940 and misusing the e-commerce landscape by operating on rock bottom prices with 30 per cent-40 per cent discount and free shipping.
It’s a case of capital dumping in these e-pharmacies by foreign behemoths which is proving extremely detrimental to the future of the lakhs of crores of small chemists across the country . The retail chemists are the last mile connectivity and emergency provisioning is ensured by brick-and-mortar retailers who in turn also provide livelihood to millions of retail pharmacies, their families and employees
The CAIT has once again reiterated while its demand for issuance of a fresh press note in lieu of Press Note 2 of the FDI policy to make Indian e-commerce trade free from all glitches and a competitive level playing field for all stakeholders and formation of a Regulatory Authority to monitor and regulate e commerce business in India.
CAIT National President B.C. Bhartia and Secretary General Praveen Khandelwal said that mushrooming of e-pharmacy is causing huge hardships to the retail chemists and distributors in the wake of anti-competitive practices like capital dumping and deep discounting leading to predatory pricing. Brick and Mortar medicine retailers, including retail chemists and distributors are the first points of contact for needy patients across the country. E-pharmacies with their financial backing by large foreign players/funds have started disrupting brick and mortar retailers due to the unmatched and often unsustainable pricing.
They further said that It is important to note that sale of prescription drugs and medicines through online medium is illegal. The legal regime, under Drugs & Cosmetics Act, 1940, does not permit home delivery of prescription medicines for which a prescription “in original” is required.
Bhartia and Khandelwal said that the e-pharmacies like Pharmeasy and Medlife indulged in deep discounting on their platforms by giving a flat discount of 30 per cent. To capture the market even further, an additional cashback of 20 per cent is extended to customers with free shipping. Effectively, this translated to a whopping discount of around 40 per cent-45 per cent with free shipping.
Predatory Pricing is done with the sole intention of eliminating the market competition. E-pharmacies have indulged in predatory pricing immediately after the lockdown by offering a 25 per cent discount on medicines and an astronomical 75 per cent discount on wellness products, a market that had begun expanding after the recent Covid-19 pandemic. While even a 25 per cent discount on medicines is capable of distorting the market, a 75 per cent discount on a market that had just begun to swell up is daylight robbery since it not only erodes the customer base of traditional retailers but also creates an unhealthy competition, one that is unsustainable in the long run.
Bhartia and Khandelwal said that by using consumer data, which is otherwise not available to traditional players, e-pharmacies like Pharmeasy & Medlife (owned by Dharmil Seth and investment from Temasek, etc.) and 1Mg (Prashant Tandon, investment from Sequoia and now slated to merge in Tata Group) Netmed of Reliance, Amazon and Flipkart have offered a minimum discount of 30 per cent at the start of the month and approximately 40 per cent discount at the end of the month to cater to the analysis and resultant trend that spending reduces end of the month.
The CAIT has demanded that beside general e-commerce where rules and policies are being flouted at a high magnitude level, the e-pharmacy has become another trade which is being targeted by these heavily funded companies to capture and monopolised at the cost of uprooting of lakhs of chemists and medicine traders across the country. Therefore, immediate intervention of the government is required to stop this menace.
Business
Sensex, Nifty Open Flat, Mixed Global Cues & Lack Of Major Domestic Triggers Keep Investor Sentiment Muted

Mumbai: Indian stock markets opened flat with a slight negative trend on Wednesday as mixed global cues and a lack of major domestic triggers kept investor sentiment muted. With the Q2 FY26 earnings season coming to an end, traders showed limited enthusiasm, leaving the indices stuck in a narrow range.
The Sensex slipped 81 points, or 0.10 per cent, to 84,592 in early trade. The Nifty also declined, dropping 34 points, or 0.13 per cent, to 25,877. “The broader benchmark Nifty 50 remains range-bound after the prior session, with resistance seen around 26,000–26,050 and near-term support in the 25,800–25,750 band — a potential accumulation zone for positional traders,” experts said. “Given this setup, a selective buy-on-dips strategy remains appropriate — apply tight trailing stop-losses, and book partial profits on rallies,” analysts mentioned.
Tata Motors PV, NTPC, Bajaj Finserv, Eternal and Sun Pharma were among the major drags on the Sensex. However, gains in HUL, Infosys, TCS, Tata Steel, Tech Mahindra, and Trent helped cushion the fall and prevented a deeper decline. In the broader market, the trend remained weak. The Nifty MidCap index slipped 0.06 per cent, while the Nifty SmallCap index fell 0.23 per cent. Sector-wise, the Nifty IT index was the only notable performer, rising 0.62 per cent as technology stocks saw selective buying.
On the other hand, real estate stocks struggled, with the Nifty Realty index emerging as the biggest loser, down 0.5 per cent. Analysts said markets may continue to remain rangebound in the absence of fresh triggers and ahead of global macroeconomic developments expected later this week. “Investors should prioritise safety at this juncture. Safety is in large caps. Large segments of the mid and small cap space are overvalued having been driven up only by liquidity flows from exuberant investors,” analysts said.
Business
Gold, silver tumble as hopes of December Fed Rate cut fade

Mumbai, Nov 18: Gold and silver prices dropped sharply in the domestic futures market on Tuesday morning as hopes of a US Federal Reserve rate cut in December faded and concerns over US tariffs eased.
This reduced the appeal of safe-haven assets like bullion. At early trade, MCX Gold December futures were trading 1.19 per cent lower at Rs 1,21,466 per 10 grams.
MCX Silver December contracts also declined 1.65 per cent to Rs 1,52,750 per kg.
“Gold has support at $4000-3965 while resistance at $4075-4110. Silver has support at $49.70-49.45 while resistance is at $50.75-51.10,” market watchers said.
“In INR gold has support at Rs1,22,350-1,21,780 while resistance at Rs1,23,750-1,24,500. Silver has support at Rs1,53,850-1,52,100 while resistance at Rs1,56,540, 1,57,280,” they added.
Internationally, gold prices slipped for the fourth straight session on Tuesday.
A stronger US dollar and weakening expectations of a rate cut next month continued to weigh on the metal.
The dollar index rose to 99.59, making gold more expensive for buyers using other currencies.
Gold, which is priced in US dollars, becomes costlier when the greenback strengthens, resulting in reduced demand.
The recent US government shutdown, which lasted a record 43 days, had delayed the release of important economic data, creating uncertainty about the condition of the world’s largest economy.
With the shutdown now over, attention has shifted to key data releases expected this week, including the September nonfarm payrolls report on Thursday.
These numbers will play a major role in shaping expectations around the US Federal Reserve’s next move on interest rates.
Meanwhile, Fed officials continue to send mixed signals on the future path of monetary policy, adding further uncertainty to the market.
With no major positive fundamental triggers in recent days, bulls remain hesitant—especially with both metals still trading at historically high levels.
“Traders now await a fresh round of US economic data later this week. Meanwhile, a firmer US Dollar Index and slightly higher 10-year Treasury yields added pressure to precious metals,” analysts said.
Business
Sensex, Nifty open lower on weak global cues

Mumbai, Nov 18: Indian stock markets opened lower on Tuesday as weak global cues weighed on investor sentiment. Both benchmark indices slipped 0.2 per cent at the opening bell.
The Sensex dropped 195 points to trade at 84,756 in early deals, while the Nifty fell 64 points to 25,949. Most heavyweight stocks were under pressure, dragging the indices down.
“Immediate resistance now lies at 26,100, followed by 26,150, while the 25,850–25,900 band is likely to offer meaningful support and serve as an accumulation zone for positional traders,” market experts said.
“These levels will remain crucial as the index navigates early weakness,” experts noted.
Tata Steel, Bajaj Finance, Bajaj Finserv, Kotak Mahindra Bank, Larsen & Toubro, Mahindra & Mahindra, Tech Mahindra, HCL Tech, Sun Pharma and Titan were among the major laggards, declining between 0.5 per cent and 1 per cent.
However, a few stocks managed to stay in positive territory. Bharat Electronics, Bharti Airtel, Axis Bank, Eternal and State Bank of India were the only gainers on the Sensex, rising up to 0.5 per cent.
Broader markets also opened weak, with the Nifty MidCap index slipping 0.25 per cent and the Nifty SmallCap index falling 0.40 per cent.
Among sectoral indices, Nifty PSU Bank was the only one to trade higher, gaining 0.25 per cent. On the other hand, Nifty Realty and Nifty Metal dropped 0.8 per cent each, while the Nifty IT index fell 0.5 per cent.
The Bank Nifty mirrored the broader market’s resilience, reflecting renewed buying momentum.
“Strong support is identified at 58,600, and a breakdown below this mark may trigger a modest decline toward 58,800,” market watchers mentioned.
“On the upside, resistance at 59,100 remains a key barrier, and a sustained breakout above this level may open the path toward 59,300, indicating potential continuation of the bullish trend,” experts stated.
-
Crime3 years agoClass 10 student jumps to death in Jaipur
-
Maharashtra1 year agoMumbai Local Train Update: Central Railway’s New Timetable Comes Into Effect; Check Full List Of Revised Timings & Stations
-
Maharashtra1 year agoMumbai To Go Toll-Free Tonight! Maharashtra Govt Announces Complete Toll Waiver For Light Motor Vehicles At All 5 Entry Points Of City
-
Maharashtra1 year agoFalse photo of Imtiaz Jaleel’s rally, exposing the fooling conspiracy
-
National News1 year agoMinistry of Railways rolls out Special Drive 4.0 with focus on digitisation, cleanliness, inclusiveness and grievance redressal
-
Maharashtra1 year agoMaharashtra Elections 2024: Mumbai Metro & BEST Services Extended Till Midnight On Voting Day
-
National News1 year agoJ&K: 4 Jawans Killed, 28 Injured After Bus Carrying BSF Personnel For Poll Duty Falls Into Gorge In Budgam; Terrifying Visuals Surface
-
Crime1 year agoBaba Siddique Murder: Mumbai Police Unable To Get Lawrence Bishnoi Custody Due To Home Ministry Order, Says Report
